BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fretellier N, Salhi M, Schroeder J, Siegmund H, Chevalier T, Bruneval P, Jestin-Mayer G, Delaloge F, Factor C, Mayer JF, Fabicki JM, Robic C, Bonnemain B, Idée JM, Corot C. Distribution profile of gadolinium in gadolinium chelate-treated renally-impaired rats: role of pharmaceutical formulation. Eur J Pharm Sci 2015;72:46-56. [PMID: 25736527 DOI: 10.1016/j.ejps.2015.02.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Bao X, Zhu W, Zhang R, Wen C, Wang L, Yan Y, Tang H, Chen Z. Synthesis and evaluation of novel angiotensin II receptor 1 antagonists as anti-hypertension drugs. Bioorganic & Medicinal Chemistry 2016;24:2023-31. [DOI: 10.1016/j.bmc.2016.03.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Thomsen HS. Generic gadolinium-based contrast agents: the future? Acta Radiol 2017;58:1285-7. [PMID: 28691527 DOI: 10.1177/0284185117719576] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
3 Affram K, Smith T, Helsper S, Rosenberg JT, Han B, Trevino J, Agyare E. Comparative study on contrast enhancement of Magnevist and Magnevist-loaded nanoparticles in pancreatic cancer PDX model monitored by MRI. Cancer Nanotechnol 2020;11:5. [PMID: 32714466 DOI: 10.1186/s12645-020-00061-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Garcia J, Liu SZ, Louie AY. Biological effects of MRI contrast agents: gadolinium retention, potential mechanisms and a role for phosphorus. Philos Trans A Math Phys Eng Sci 2017;375:20170180. [PMID: 29038383 DOI: 10.1098/rsta.2017.0180] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
5 Bonechi C, Consumi M, Matteucci M, Tamasi G, Donati A, Leone G, Menichetti L, Kusmic C, Rossi C, Magnani A. Distribution of Gadolinium in Rat Heart Studied by Fast Field Cycling Relaxometry and Imaging SIMS. Int J Mol Sci 2019;20:E1339. [PMID: 30884846 DOI: 10.3390/ijms20061339] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Bussi S, Penard L, Bonafè R, Botteron C, Celeste R, Coppo A, Queliti R, Kirchin MA, Tedoldi F, Maisano F. Non-clinical assessment of safety and gadolinium deposition after cumulative administration of gadobenate dimeglumine (MultiHance®) to neonatal and juvenile rats. Regul Toxicol Pharmacol 2018;92:268-77. [PMID: 29278694 DOI: 10.1016/j.yrtph.2017.12.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hanana H, Turcotte P, André C, Gagnon C, Gagné F. Comparative study of the effects of gadolinium chloride and gadolinium – based magnetic resonance imaging contrast agent on freshwater mussel, Dreissena polymorpha. Chemosphere 2017;181:197-207. [DOI: 10.1016/j.chemosphere.2017.04.073] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
8 Myrissa A, Braeuer S, Martinelli E, Willumeit-römer R, Goessler W, Weinberg AM. Gadolinium accumulation in organs of Sprague–Dawley® rats after implantation of a biodegradable magnesium-gadolinium alloy. Acta Biomaterialia 2017;48:521-9. [DOI: 10.1016/j.actbio.2016.11.024] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 8.4] [Reference Citation Analysis]
9 Mercantepe T, Tümkaya L, Çeliker FB, Topal Suzan Z, Çinar S, Akyildiz K, Mercantepe F, Yilmaz A. Effects of gadolinium-based MRI contrast agents on liver tissue. J Magn Reson Imaging 2018;48:1367-74. [PMID: 29607566 DOI: 10.1002/jmri.26031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Wallnöfer EA, Thurner GC, Kremser C, Talasz H, Stollenwerk MM, Helbok A, Klammsteiner N, Albrecht-Schgoer K, Dietrich H, Jaschke W, Debbage P. Albumin-based nanoparticles as contrast medium for MRI: vascular imaging, tissue and cell interactions, and pharmacokinetics of second-generation nanoparticles. Histochem Cell Biol 2021;155:19-73. [PMID: 33040183 DOI: 10.1007/s00418-020-01919-0] [Reference Citation Analysis]
11 Stinnett G, Taheri N, Villanova J, Bohloul A, Guo X, Esposito EP, Xiao Z, Stueber D, Avendano C, Decuzzi P, Pautler RG, Colvin VL. 2D Gadolinium Oxide Nanoplates as T1 Magnetic Resonance Imaging Contrast Agents. Adv Healthc Mater 2021;10:e2001780. [PMID: 33882196 DOI: 10.1002/adhm.202001780] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]